Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Muscle Maker, Inc. (GRIL)
|
Add to portfolio |
|
|
|
| Price: |
$0.71
| | Metrics |
| OS: |
46.1
|
M
| |
-22
|
% ROE
|
| Market cap: |
$32.9
|
M
| |
-32
|
% ROIC
|
|
Net cash:
|
$578
|
k
| |
$0.01
|
per share
|
|
EV:
|
$32.3
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($3.9)
|
M
| |
|
|
|
EBIT
|
($6.0)
|
M
| |
|
|
| EPS |
($0.18)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 161.7 | 10.3 | 4.5 | 5.0 | 6.0 | 7.9 | 5.0 |
| Revenue growth | 1462.4% | 131.4% | -9.8% | -17.7% | -24.0% | 60.1% | |
| Cost of goods sold | 11.3 | 9.1 | 5.2 | 3.9 | 4.7 | 7.1 | 2.0 |
| Gross profit | 150.4 | 1.3 | -0.7 | 1.0 | 1.3 | 0.8 | 2.9 |
| Gross margin | 93.0% | 12.5% | -16.6% | 20.4% | 21.3% | 10.2% | 58.9% |
| Selling, general and administrative | 6.2 | 8.3 | | | | | |
| Sales and marketing | 0.1 | 0.2 | 0.1 | 0.1 | | | |
| General and administrative | | | 8.6 | 4.2 | 4.4 | 8.0 | 4.8 |
| EBITA | -6.3 | -7.5 | -9.8 | -3.6 | -4.0 | -7.5 | -3.9 |
| EBITA margin | -3.9% | -72.4% | -219.0% | -72.4% | -66.2% | -94.8% | -77.8% |
| Amortization of intangibles | 1.4 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| EBIT | -7.8 | -8.1 | -9.9 | -3.7 | -4.1 | -7.6 | -4.0 |
| EBIT margin | -4.8% | -78.6% | -220.4% | -73.7% | -67.3% | -96.1% | -80.1% |
| Pre-tax income | -7.9 | -8.2 | -10.1 | -28.4 | -7.2 | -15.8 | -4.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.1 |
| Tax rate | | | 0.0% | 0.0% | 0.0% | 1.6% | |
| Net income | -8.0 | -8.2 | -10.1 | -28.4 | -7.2 | -13.2 | -3.1 |
| Net margin | -4.9% | -79.0% | -225.8% | -572.4% | -119.6% | -166.6% | -62.8% |
| |
| Diluted EPS | ($0.28) | ($0.50) | ($1.33) | ($17.58) | ($5.66) | ($2.19) | ($0.51) |
| Shares outstanding (diluted) | 28.6 | 16.5 | 7.6 | 1.6 | 1.3 | 6.0 | 6.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|